Open AccessCombining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease
Author(s) -
Leonardo Brunetti,
Antonio Laghezza,
Fulvio Loiodice,
Paolo Tortorella,
Luca Piemontese
Publication year - 2020
Publication title -
neural regeneration research/neural regeneration research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.93
H-Index - 38
eISSN - 1876-7958
pISSN - 1673-5374
DOI - 10.4103/1673-5374.264458
Subject(s) - context (archaeology) , fatty acid amide hydrolase , disease , neurodegeneration , medicine , neuroscience , amyloid beta , bioinformatics , butyrylcholinesterase , neuroprotection , alzheimer's disease , endocannabinoid system , acetylcholinesterase , psychology , receptor , biology , cannabinoid receptor , aché , biochemistry , agonist , paleontology , enzyme